MAI Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
MAI Capital Management's NEO Position: Q2 2026 in Review
MAI Capital Management increased its NeoGenomics (NEO) stake by 13% in Q2 2026, buying an estimated $17.7K and bringing the position to 16,267 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1718.
MAI Capital Management first reported a position in NEO in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.17M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- MAI Capital Management held 16,267 shares of NeoGenomics worth $237K as of Q2 2026.
- MAI Capital Management bought 1,831 NeoGenomics shares in Q2 2026, an estimated $17.7K.
- NeoGenomics made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1718 holding.
- MAI Capital Management first reported a position in NeoGenomics in Q3 2020 and has held it in 24 quarters since.
- MAI Capital Management's NeoGenomics position peaked at $1.17M in Q3 2021.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.